zilurgisertib
zilurgisertib: 3 clinical trials tracked.
zilurgisertib evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
What is verified about zilurgisertib, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (3)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
Primary endpoint: Double Blind Period: Occurrence of new heterotopic ossification (HO) lesions from baseline
A Phase 1/2, Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy in Participants With Anemia Due to Myelodysplastic Syndromes or Multiple Myeloma
Primary endpoint: Number of Participants With Any Treatment-emergent Adverse Event (TEAE)
A Phase 1/2 Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
Primary endpoint: Number of Participants With Any Treatment-emergent Adverse Event (TEAE) and Any Treatment-emergent Serious Adverse Event (SAE)